Skip to main content
GOSS
NASDAQ Life Sciences

Gossamer Bio Faces Securities Class Action Over Failed Phase 3 Trial Disclosures

Tom Rudovsky · Reported by PR Newswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.238
Mkt Cap
$50.53M
52W Low
$0.163
52W High
$3.87
52W Position info
47% above low
Off High info
94% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

GOSS sits 47% above its 52-week low of $0.163.

Summary

Hagens Berman has filed a securities class action lawsuit against Gossamer Bio, alleging the company misled investors regarding the design and patient recruitment for its Phase 3 PROSERA trial. This legal action follows the February 23, 2026 announcement of the trial's failure, which caused an 80% stock decline. While the company's May 15, 2026 10-Q mentioned a class-action lawsuit, this news provides specific details on the firm and the allegations. This lawsuit further compounds the company's significant financial challenges, including a going concern warning, a Nasdaq delisting notice, and a recently initiated distressed debt exchange.

At the time of this announcement, GOSS was trading at $0.24 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $50.5M. The 52-week trading range was $0.16 to $3.87. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: PR Newswire.


Price Chart

Share this article

Copied!

GOSS - Latest Insights

GOSS
Nov 10, 2026, 4:49 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $10.15
Real-time Price: $10.97 info
Change: +$0.8155 (+8%) info
Market Cap: $65.568M info
GOSS
Sep 23, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $11.19
Real-time Price: $10.97 info
Change: -$0.227 (-2%) info
Market Cap: $65.568M info
GOSS
Sep 23, 2026, 4:01 PM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $11.00
Real-time Price: $10.97 info
Change: -$0.0345 (-0.31%) info
Market Cap: $65.568M info
GOSS
Sep 16, 2026, 4:30 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $10.93
Real-time Price: $10.97 info
Change: +$0.0355 (+0.32%) info
Market Cap: $65.568M info
GOSS
Sep 11, 2026, 8:01 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.1562
Real-time Price: $10.97 info
Change: Reverse Stock Split info
Market Cap: $65.568M info